Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Rating) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,740,000 shares, a drop of 10.3% from the March 31st total of 1,940,000 shares. Based on an average trading volume of 188,800 shares, the […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Rating) EVP Antoine Yver sold 6,800 shares of Centessa Pharmaceuticals stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $4.42, for a total value of $30,056.00. Following the completion of the sale, the executive vice president now directly owns 789,566 shares […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,740,000 shares, a drop of 10.3% from the March 31st total of 1,940,000 shares. Based on an average daily trading volume, of 188,800 shares, […]
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Rating) has been given an average rating of “Hold” by the six research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation to the company. […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Rating) have earned an average rating of “Hold” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the […]